ADVFN - ニュース

S&P 500

5,277.51

0.80%

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

銘柄名/コード:

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/03	19 : 07	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:RDY	Dr Reddys Laboratories Ltd
2024/06/03	19 : 06	Business Wire	Jack in the Box Announces Continued Florida Expansion with New Franchise Commitments	NASDAQ:JACK	Jack in the Box Inc
2024/06/03	19 : 05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:TNRSF	Tenaris SA Luxembourg (PK)
2024/06/03	19 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LAB	Standard BioTools Inc
2024/06/03	19 : 05	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:APTO	Aptose Biosciences Inc
2024/06/03	19 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SMMT	Summit Therapeutics Inc
2024/06/03	19 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/06/03	19 : 05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:GLAXF	GSK Plc (PK)
2024/06/03	19 : 05	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NYSE:SMLP	Summit Midstream Partners LP
2024/06/03	19 : 05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	AMEX:CMCL	Caledonia Mining Corporation Plc
2024/06/03	19 : 05	GlobeNewswire Inc.	IN8bio Presents Progression-Free Survival Update from Phase 1 Study of INB-200 at 2024 American Society of Clinical Oncology Annual Meeting	NASDAQ:INAB	IN8bio Inc
2024/06/03	19 : 05	PR Newswire (US)	Chance Miller Promoted to Senior Associate at Xite Healthcare Real Estate and Practice Sales
2024/06/03	19 : 05	PR Newswire (Canada)	Shifting perspectives: Canada's opportunity to lead amid disruptive forces
2024/06/03	19 : 05	PR Newswire (Canada)	Changement d'optique : l'occasion pour le Canada de jouer un rôle de premier plan dans un contexte de forces perturbatrices
2024/06/03	19 : 04	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	NASDAQ:LABP	Landos Biopharma Inc
2024/06/03	19 : 04	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:AFMD	Affimed NV
2024/06/03	19 : 04	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OPT	Opthea Ltd
2024/06/03	19 : 03	Alliance News	French government faces confidence motions ahead of EU vote
2024/06/03	19 : 03	GlobeNewswire Inc.	Fanhua Announces Strategic Partnership with Baidu AI Cloud for Application of Large Model in Insurance Distribution	NASDAQ:FANH	Fanhua Inc
2024/06/03	19 : 03	Edgar (US Regulatory)	Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]	NYSE:ICL	ICL Group Ltd
2024/06/03	19 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:SMLP	Summit Midstream Partners LP
2024/06/03	19 : 03	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VMAR	Vision Marine Technologies Inc
2024/06/03	19 : 02	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:KDCE	Kid Castle Educational Corporation (PK)
2024/06/03	19 : 02	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:CHUC	Charlies Holdings Inc (QB)
2024/06/03	19 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZURAW	Zura Bio Ltd
2024/06/03	19 : 02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NIOIF	NIO Inc (PK)
2024/06/03	19 : 02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:ZK	ZEEKR Intelligent Technology Holding Limited
2024/06/03	19 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GECCZ	Great Elm Capital Corporation
2024/06/03	19 : 02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	AMEX:GROY	Gold Royalty Corp
2024/06/03	19 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRBU	Caribou Biosciences Inc